Some experts say that 50% of drug launches fail. Others say it s as high as 90%. From my perspective, judging launches in such black-and-white terms isn t particularly useful. Instead, I look at the market performance of a new drug like the debut of a cruise ship. Given the incredible amount ofOriginal Article
You may also like
Nouscom to present re‑treatment data in Lynch...
ViiV Healthcare to unveil new HIV treatment data at...
Almirall’s paediatric registration of Ebglyss for...
The Bloc appoints Jon Chapman as European Executive...
UCSD, IGI Partnership Expands CRISPR Innovation Across...
10x Clinical Expansion Advances with CLIA Lab Plans...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
